简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-01-17 11:22 Xenco Medical Unveils the TrabeculeX Continuum, a Breakthrough Convergence of Digital Health and Biomaterials, at CES 2024 in Las Vegas, the World’s Largest Technology Conference
2024-01-17 10:56 KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions
2024-01-17 09:03 Women's Health Remains in Crisis Worldwide Even as COVID-19 Pandemic Wanes
2024-01-17 09:01 U.S. FDA Approves Takeda’s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2024-01-16 10:35 Neuraptive Therapeutics Inc. Receives Orphan Drug Designation for its Lead Development Asset
2024-01-12 12:29 ELIQUENT Life Sciences Announces Steve Purtell as Chief Financial Officer
2024-01-11 10:13 QPS Significantly Enhances Mass Spectrometry Laboratory Capacity
2024-01-11 09:10 Medidata Secures Top Honors in Everest Group's Decentralized Clinical Trial Platforms PEAK Matrix® Assessment
2024-01-11 09:03 Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential
2024-01-10 10:15 World’s First Kidney Tumor Treated Using the HistoSonics’ Edison® Histotripsy System
2024-01-09 10:20 Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in The NEUROFUSE Study of NTX-001 for the Adjunct Treatment of Transected Peripheral Nerves
2024-01-09 10:15 Validant Group of Companies Unite as ELIQUENT Life Sciences
2024-01-09 09:51 ENYO Pharma Announces a €39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With Alport Syndrome
2024-01-09 09:48 Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma
2024-01-08 11:29 World’s First Patients Treated With Novel Edison® Histotripsy System
2024-01-08 11:04 Kenvue to Announce Fourth Quarter and Full Year 2023 Results on February 8, 2024
2024-01-05 12:26 ReNAgade to Present at the Upcoming 42nd Annual J.P. Morgan Healthcare Conference
2024-01-05 12:19 Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
2023-12-28 15:00 Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager
2023-12-28 09:29 CCM Biosciences Announces Launch of 5Prime Sciences Business Unit

Business Wire Weibo

Press Releases

Latest Releases